Abstract
Chelation therapy occupies a central place in modern medicine and pharmacology, because continuous studies with laboratory animals and extensive clinical experience demonstrate that acute or chronic intoxications with a variety of metals can be considerable improved by administration of a suitable chelating agent. In this review the chemical characteristics, properties and uses of the most common chelating agents as well as those of some new and very promising agents of this type, are discussed. In the second part of the review the biological and biochemical impact of these agents, as well as their use for the treatment of some selected diseases and disorders, are also analyzed and discussed in detail.
Keywords: Toxic metals, chelating agents, chemical characteristics, biological effects, Chelation Therapies, Bioinorganic Chemistry, biolixiviation, remediation, decon-tamination, metal-based drugs, Bertrand diagram, chelation therapy, ligand-to-metal interaction, hard-soft acid-base concept (HSAB), non-essential toxic elements, 2,3-dimercaptopropanol (BAL), Ethylenediaminetetraacetic acid (EDTA), hypocalcemia, nephrotoxic, atherosclerosis, DTPA, CDTA, TTHA, Polyaminopolycarboxylic Acids, Monoalkyl Esters of DMSA, Lipoic Acid (LA), Dihydrolipoic Acid (DHLA), Metal Intoxications, potentiate cadmium toxicity, Vanadium Toxicity, polyaminopolyarboxylic acids, Alzheimer disease, Wilson Disease, Cu/metallothionein, D-penicillamine, nephritic syndrome, autoimmune reactions, (TETA), Desferrioxamine B, deferiprone, deferasirox, macrophages, hepatocytes, plaques, Parkinson's disease, Huntington's disease, blood-brain-barrier, metal-protein attenuating compound (MPAC), clioquinol (CQ), 2-2'-methilenedi-8-quinolinol
Current Medicinal Chemistry
Title: Chelation Therapies: A Chemical and Biochemical Perspective
Volume: 17 Issue: 31
Author(s): E. J. Baran
Affiliation:
Keywords: Toxic metals, chelating agents, chemical characteristics, biological effects, Chelation Therapies, Bioinorganic Chemistry, biolixiviation, remediation, decon-tamination, metal-based drugs, Bertrand diagram, chelation therapy, ligand-to-metal interaction, hard-soft acid-base concept (HSAB), non-essential toxic elements, 2,3-dimercaptopropanol (BAL), Ethylenediaminetetraacetic acid (EDTA), hypocalcemia, nephrotoxic, atherosclerosis, DTPA, CDTA, TTHA, Polyaminopolycarboxylic Acids, Monoalkyl Esters of DMSA, Lipoic Acid (LA), Dihydrolipoic Acid (DHLA), Metal Intoxications, potentiate cadmium toxicity, Vanadium Toxicity, polyaminopolyarboxylic acids, Alzheimer disease, Wilson Disease, Cu/metallothionein, D-penicillamine, nephritic syndrome, autoimmune reactions, (TETA), Desferrioxamine B, deferiprone, deferasirox, macrophages, hepatocytes, plaques, Parkinson's disease, Huntington's disease, blood-brain-barrier, metal-protein attenuating compound (MPAC), clioquinol (CQ), 2-2'-methilenedi-8-quinolinol
Abstract: Chelation therapy occupies a central place in modern medicine and pharmacology, because continuous studies with laboratory animals and extensive clinical experience demonstrate that acute or chronic intoxications with a variety of metals can be considerable improved by administration of a suitable chelating agent. In this review the chemical characteristics, properties and uses of the most common chelating agents as well as those of some new and very promising agents of this type, are discussed. In the second part of the review the biological and biochemical impact of these agents, as well as their use for the treatment of some selected diseases and disorders, are also analyzed and discussed in detail.
Export Options
About this article
Cite this article as:
J. Baran E., Chelation Therapies: A Chemical and Biochemical Perspective, Current Medicinal Chemistry 2010; 17 (31) . https://dx.doi.org/10.2174/092986710793213760
DOI https://dx.doi.org/10.2174/092986710793213760 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Towards Drug Discovery for Brain Tumours: Interaction of Kinins and Tumours at the Blood Brain Barrier Interface
Recent Patents on CNS Drug Discovery (Discontinued) Affective Risk for Problem Drinking: Reciprocal Influences Among Negative Urgency, Affective Lability, and Rumination
Current Drug Research Reviews Glutamate and Multiple Sclerosis
Current Medicinal Chemistry Pharmacological Risk Factors for Delirium after Cardiac Surgery: A Review
Current Neuropharmacology Chronic Effects of Cocaine on Dopaminergic and Serotonergic Systems of Rats
Current Molecular Imaging (Discontinued) Disease Progression in HIV Late Presenters: the Role of HIV Clinical Indicator Diseases Prior to HIV Diagnosis
Current HIV Research Subject Index to Volume 1
Current Pharmacogenomics Nano Era of Dentistry-An Update
Current Drug Delivery Thalidomide and Analogs as Anti-Inflammatory and Immunomodulator Drug Candidates
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Aging is Neuroprotective During Global Ischemia but Leads to Increased Caspase-3 and Apoptotic Activity in Hippocampal Neurons
Current Neurovascular Research Coronary Artery Disease in Patients with Chronic Kidney Disease: A Clinical Update
Current Cardiology Reviews Do Insecticides have Adverse Effects on Reproduction
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Applications of Chemical Shift Imaging for AD
Current Medical Imaging From Stem Cells to Dopamine Neurons: Developmental Biology Meets Neurodegeneration
CNS & Neurological Disorders - Drug Targets Mitochondrial Disorders in Adults
Current Molecular Medicine CD14-Dependent Innate Immunity-Mediated Neuronal Damage in Vivo is Suppressed by NSAIDs and Ablation of a Prostaglandin E2 Receptor, EP2
Current Medicinal Chemistry - Central Nervous System Agents The Potential of Tetrandrine Against Gliomas
Anti-Cancer Agents in Medicinal Chemistry Tyrosine Hydroxylase Gene: Another Piece of the Genetic Puzzle of Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options
Current Neuropharmacology Characterization of Cancer Stem Cells and Primary Cilia in Medulloblastoma
CNS & Neurological Disorders - Drug Targets